Jagsonpal Pharmaceuticals Ltd approves Q2 FY27 results, reporting consolidated revenue of ₹96.50 crore and net profit of ₹12.29 crore
- Consolidated operating margin was approximately 15.4%; standalone revenue was ₹81.38 crore, up 9.3% year on year and down 1.0% sequentially.
- Results included ₹23.5 lakh in exceptional acquisition-related expenses.
- Auditors issued unmodified limited-review conclusions.